Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesMesalazine for ulcerative colitis: evidence for use
Nurse Prescribing, 09/02/09
Greveson K – Ulcerative colitis is a chronic, idiopathic inflammatory disease of the colon characterized by periods of exacerbation and remission. Medical treatment aims to provide rapid effective relief from symptoms, modify the disease process and improve quality of life. Many oral preparations use multiple daily dosing regimens which can be inconvenient and affect treatment adherence leading to increased morbidity and risk of symptomatic relapse. This article examines the issues surrounding the use of mesalazine in ulcerative colitis, focusing on Mezavant XL (MMX mesalazine), a once–daily dosing formulation with patented multi–matrix system.
Related Articles
Quality of Life Improvements Attributed to Combination Therapy with Oral and Topical Mesalazine in Mild-to-Moderately Active Ulcerative Colitis
Digestion, 10/15/09
Relevance Score: 87%
Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis
Scandinavian Journal of Gastroenterology, 11/06/09
Relevance Score: 84%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease
World Journal of Gastroenterology, 12/14/09
Analysis of Court Criteria for Awarding Disability Benefits to Patients With Crohn's Disease
Clinical Gastroenterology and Hepatology , 12/14/09
Protection of Epithelial Barrier Function by the Crohn's Disease Associated Gene Protein Tyrosine Phosphatase N2
Gastroenterology, 12/14/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Spontaneous bacterial peritonitis: Few additional points
World Journal of Gastroenterology, 12/14/09
Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results
Diseases of the Esophagus, 12/14/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/14/09
Sponsor
Article Search
Sponsor
Sponsor